Immunostimulatory nanoparticle incorporating two immune agonists for the treatment of pancreatic tumors

Pancreatic ductal adenocarcinoma (PDAC) is a highly malignant disease, where even surgical resection and aggressive chemotherapy produce dismal outcomes. Immunotherapy is a promising alternative to conventional treatments, possessing the ability to elicit T cell-mediated killing of tumor cells and p...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:J Control Release
Huvudupphovsmän: Lorkowski, M.E., Atukorale, P.U., Bielecki, P.A., Tong, K.H., Covarrubias, G., Zhang, Y., Loutrianakis, G., Moon, T.J., Santulli, A.R., Becicka, W.M., Karathanasis, E.
Materialtyp: Artigo
Språk:Inglês
Publicerad: 2020
Ämnen:
Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC7906920/
https://ncbi.nlm.nih.gov/pubmed/33188827
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jconrel.2020.11.014
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk